The US Food and Drug Administration (FDA) has approved osimertinib (Tagrisso, AstraZeneca Pharmaceuticals) for the treatment ...

Tagrisso, which targets exon 19 deletions or exon 21 (L858R) mutations, received the approval following a priority review.

The Zacks Daily presents the best research output of our analyst team. Today's Daily features new research reports on 16 ...

Former prime minister Boris Johnson considered launching an “aquatic raid” on a warehouse in the Netherlands to retrieve ...

Boris Johnson considered invading the Netherlands to seize Covid vaccines during the height of the pandemic, he has revealed ...

In several short films directed by Reed Morano, the “What science can do” campaign features stories from a cancer patient and an asthma patient.

AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm's AI model of the immune ...

Boris Johnson says he considered a proposal to send UK special forces into the Netherlands to grab Covid vaccines during a ...

Johnson convened a meeting of senior military officials in March 2021 to discuss the plans, which he admitted were “nuts”.

According to GlobalData, the US vaccination rate for seasonal influenza during the 2023-2024 season was estimated to be 47%, ...

AstraZeneca and Daiichi Sankyo's Dato-DXd failed to improve survival in a breast cancer study. Gilead Sciences' Kite will bow ...